ID

32541

Description

A Study for Patients With Non-Hodgkin's Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT00542919

Link

https://clinicaltrials.gov/show/NCT00542919

Keywords

Versions (1)
  1. 11/6/18 11/6/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 6, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility T-Cell Lymphoma NCT00542919

English

Eligibility T-Cell Lymphoma NCT00542919

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
have measurable lesions
Description

Measurable lesion

Data type

boolean

Alias
UMLS CUI [1]
C1513041
have recovered from prior chemotherapies
Description

Prior Chemotherapy Patient recovered

Data type

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1115804
have an estimated life expectancy of at least 12 weeks
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
hepatic: total bilirubin less than or equal to 1.5 xuln; atl/ast less than or equal to 2.0 x uln (less than 5x if liver metastases are present)
Description

Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Relationship Secondary malignant neoplasm of liver

Data type

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201899
UMLS CUI [5,1]
C0439849
UMLS CUI [5,2]
C0494165
renal: serum creatinine less than or equal to 1.5xuln
Description

Renal function | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
adequate bone marrow reserve: platelets greater than or equal to 75 x 109 /l, absolute neutrophil count (anc) greater than or equal to 1.0 x 09 /l
Description

Bone Marrow Mature Neutrophils Present Adequate | Platelet Count measurement | Absolute neutrophil count

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C1708947
UMLS CUI [1,3]
C0205411
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0948762
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
have a second primary malignancy (except adequately treated nonmelanomatous skin cancer, or other cancer that is considered cured by surgical resection or radiation).
Description

Second Primary Cancer | Exception Skin carcinoma Treated | Exception Cancer Other Cured Excision | Exception Cancer Other Cured Therapeutic radiology procedure

Data type

boolean

Alias
UMLS CUI [1]
C0751623
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C1707251
UMLS CUI [3,3]
C1880198
UMLS CUI [3,4]
C0728940
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1707251
UMLS CUI [4,3]
C1880198
UMLS CUI [4,4]
C1522449
anti-lymphoma therapy within the past 3 weeks
Description

Therapeutic procedure Against Lymphoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0521124
UMLS CUI [1,3]
C0024299
unable to swallow tablets
Description

Lacking Able to swallow Tablets

Data type

boolean

Alias
UMLS CUI [1,1]
C0332268
UMLS CUI [1,2]
C2712086
UMLS CUI [1,3]
C0039225
unable to discontinue use of carbamazepine, phenobarbital and phenytoin at least 14 days prior to study enrollment
Description

Carbamazepine Discontinue Unable | Phenobarbital Discontinue Unable | Phenytoin Discontinue Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0006949
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C0031412
UMLS CUI [2,2]
C1444662
UMLS CUI [2,3]
C1299582
UMLS CUI [3,1]
C0031507
UMLS CUI [3,2]
C1444662
UMLS CUI [3,3]
C1299582
Back to the top of the page

Similar models

Eligibility T-Cell Lymphoma NCT00542919

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Measurable lesion
Item
have measurable lesions
boolean
C1513041 (UMLS CUI [1])
Prior Chemotherapy Patient recovered
Item
have recovered from prior chemotherapies
boolean
C1514457 (UMLS CUI [1,1])
C1115804 (UMLS CUI [1,2])
Life Expectancy
Item
have an estimated life expectancy of at least 12 weeks
boolean
C0023671 (UMLS CUI [1])
Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Relationship Secondary malignant neoplasm of liver
Item
hepatic: total bilirubin less than or equal to 1.5 xuln; atl/ast less than or equal to 2.0 x uln (less than 5x if liver metastases are present)
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
C0439849 (UMLS CUI [5,1])
C0494165 (UMLS CUI [5,2])
Renal function | Creatinine measurement, serum
Item
renal: serum creatinine less than or equal to 1.5xuln
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Bone Marrow Mature Neutrophils Present Adequate | Platelet Count measurement | Absolute neutrophil count
Item
adequate bone marrow reserve: platelets greater than or equal to 75 x 109 /l, absolute neutrophil count (anc) greater than or equal to 1.0 x 09 /l
boolean
C0005953 (UMLS CUI [1,1])
C1708947 (UMLS CUI [1,2])
C0205411 (UMLS CUI [1,3])
C0032181 (UMLS CUI [2])
C0948762 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Second Primary Cancer | Exception Skin carcinoma Treated | Exception Cancer Other Cured Excision | Exception Cancer Other Cured Therapeutic radiology procedure
Item
have a second primary malignancy (except adequately treated nonmelanomatous skin cancer, or other cancer that is considered cured by surgical resection or radiation).
boolean
C0751623 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C1707251 (UMLS CUI [3,2])
C1880198 (UMLS CUI [3,3])
C0728940 (UMLS CUI [3,4])
C1705847 (UMLS CUI [4,1])
C1707251 (UMLS CUI [4,2])
C1880198 (UMLS CUI [4,3])
C1522449 (UMLS CUI [4,4])
Therapeutic procedure Against Lymphoma
Item
anti-lymphoma therapy within the past 3 weeks
boolean
C0087111 (UMLS CUI [1,1])
C0521124 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
Lacking Able to swallow Tablets
Item
unable to swallow tablets
boolean
C0332268 (UMLS CUI [1,1])
C2712086 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,3])
Carbamazepine Discontinue Unable | Phenobarbital Discontinue Unable | Phenytoin Discontinue Unable
Item
unable to discontinue use of carbamazepine, phenobarbital and phenytoin at least 14 days prior to study enrollment
boolean
C0006949 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0031412 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
C0031507 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C1299582 (UMLS CUI [3,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial